AA
Aardvark Therapeutics, Inc.
Nasdaq : AARDHealthcare · Pharmaceutical Preparations
Mkt Cap$117.74MShares Out21.88M30d Avg Vol31.43MShort Int509.89KShort Float2.33%IPOFeb 13, 2025
▲+7.71%
$73.36
–
| Form | Description | Filed |
|---|---|---|
| SC 13G | Beneficial Ownership Report1 | Jun 30, 2026 |
| 13F-HR | Institutional Holdings Report | Jun 30, 2026 |
| 8-K | 2.02 | Jun 30, 2026 |
| 144 | Notice of Proposed Sale of Securities | Jun 24, 2026 |
| 13F-HR | Institutional Holdings Report | Jun 24, 2026 |
| 424B5 | Prospectus Supplement2 | Jun 22, 2026 |
| 8-K | 8.01,9.01 | Jun 17, 2026 |
| 8-K | 1.01,9.01 | Jun 17, 2026 |
| 144 | Notice of Proposed Sale of Securities | Jun 13, 2026 |
| 13F-HR | Institutional Holdings Report | Jun 10, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 4, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | Jun 4, 2026 |
| 3 | Initial Statement of Beneficial Ownership | Jun 4, 2026 |
| 13F-HR | Institutional Holdings Report | May 31, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 28, 2026 |
| 144 | Notice of Proposed Sale of Securities | May 23, 2026 |
| 8-K | 2.02 | May 22, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 16, 2026 |
| SC 13G/A | Beneficial Ownership Report (Amended) | May 14, 2026 |
| 5 | Annual Statement of Beneficial Ownership | May 14, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 14, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 9, 2026 |
| 8-K | 8.01,9.01 | May 9, 2026 |
| 4 | Statement of Changes in Beneficial Ownership3 | May 9, 2026 |
| 4 | Statement of Changes in Beneficial Ownership | May 6, 2026 |
1-25 of 210 filings
…